Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments

Barriers and facilitators to implementing medications for opioid use disorder and naloxone... INTRODUCTIONEmergency departments (ED) can play a significant role in providing people with opioid use disorder access to lifesaving harm reduction therapies such as medications‐assisted therapies (e.g., buprenorphine) and overdose prevention (e.g., naloxone).1 The ED is an integral part of the health care system, improving access for those patients with OUD who may be: (1) high risk, (2) difficult to reach, and (3) both high risk and difficult to reach. For example, in a study by D'Onofrio et al.2 patients who were started on OUD treatment in the ED and had brief interviews were two times more likely to continue treatment at 30 days compared to those patients given referrals to substance use disorder care only or referral plus interview. Despite policy statements and professional guidelines from national organizations like the American College of Emergency Physicians,3 National Institute on Drug Abuse,4 and the Substance Abuse and Mental Health Services Administration,5 medications (e.g., buprenorphine) for OUD and naloxone for overdose prevention are still not commonly prescribed in the ED.Prior research in community and academic settings has identified some possible reasons why patients may not be prescribed medications for opioid use disorder (M‐OUD) or naloxone in the ED.6–9 Lack of knowledge and awareness http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Academic Emergency Medicine Wiley

Barriers and facilitators to implementing medications for opioid use disorder and naloxone distribution in Veterans Affairs emergency departments

Download PDF
10 pages

Loading next page...
 
/lp/wiley/barriers-and-facilitators-to-implementing-medications-for-opioid-use-qyMe5e0BD0

References (29)

Publisher
Wiley
Copyright
Copyright © 2023 Society for Academic Emergency Medicine
ISSN
1069-6563
eISSN
1553-2712
DOI
10.1111/acem.14683
Publisher site
See Article on Publisher Site

Abstract

INTRODUCTIONEmergency departments (ED) can play a significant role in providing people with opioid use disorder access to lifesaving harm reduction therapies such as medications‐assisted therapies (e.g., buprenorphine) and overdose prevention (e.g., naloxone).1 The ED is an integral part of the health care system, improving access for those patients with OUD who may be: (1) high risk, (2) difficult to reach, and (3) both high risk and difficult to reach. For example, in a study by D'Onofrio et al.2 patients who were started on OUD treatment in the ED and had brief interviews were two times more likely to continue treatment at 30 days compared to those patients given referrals to substance use disorder care only or referral plus interview. Despite policy statements and professional guidelines from national organizations like the American College of Emergency Physicians,3 National Institute on Drug Abuse,4 and the Substance Abuse and Mental Health Services Administration,5 medications (e.g., buprenorphine) for OUD and naloxone for overdose prevention are still not commonly prescribed in the ED.Prior research in community and academic settings has identified some possible reasons why patients may not be prescribed medications for opioid use disorder (M‐OUD) or naloxone in the ED.6–9 Lack of knowledge and awareness

Journal

Academic Emergency Medicine – Wiley

Published: Apr 1, 2023

Keywords: emergency department; M‐OUD; naloxone; opioid‐related disorders; Veterans; Veterans health

There are no references for this article.